{"id":"NCT02559895","sponsor":"Alder Biopharmaceuticals, Inc.","briefTitle":"A Multicenter Assessment of ALD403 in Frequent Episodic Migraine","officialTitle":"A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09","primaryCompletion":"2017-02","completion":"2017-12","firstPosted":"2015-09-25","resultsPosted":"2020-05-14","lastUpdate":"2020-05-14"},"enrollment":898,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Migraine Disorders"],"interventions":[{"type":"DRUG","name":"ALD403","otherNames":["Eptinezumab-jjmr","Vyepti"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"ALD403 Dose Level 1","type":"EXPERIMENTAL"},{"label":"ALD403 Dose Level 2","type":"EXPERIMENTAL"},{"label":"ALD403 Dose Level 3","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess ALD403 in the prevention of migraine headache in frequent episodic migraineurs.","primaryOutcome":{"measure":"Change From Baseline in Monthly Migraine Days (Weeks 1-12)","timeFrame":"Week 1-12","effectByArm":[{"arm":"300 mg ALD403","deltaMin":-4.3,"sd":3.42},{"arm":"100 mg ALD403","deltaMin":-3.9,"sd":3.23},{"arm":"30 mg ALD403","deltaMin":-4.1,"sd":3.22},{"arm":"Placebo","deltaMin":-3.1,"sd":3.7}],"pValues":[{"comp":"OG000 vs OG003","p":"0.0001"},{"comp":"OG001 vs OG003","p":"0.0182"},{"comp":"OG002 vs OG003","p":"0.0046"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":87,"countries":["United States","Georgia"]},"refs":{"pmids":["36284281","35436857","35302389","35131090","35130836","34823467","33781209","33250209","32075406"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":224},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Sinusitis"]}}